LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹43 Cr | ₹27 Cr | ₹20 Cr | ₹18 Cr | ₹8.67 Cr |
What is the latest Sundry Debtors ratio of LYKA LABS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹43 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹18 Cr |
| Mar2021 | ₹8.67 Cr |
How is Sundry Debtors of LYKA LABS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹43 Cr | 59.59 | |
| Mar2024 | ₹27 Cr | 34.12 | |
| Mar2023 | ₹20 Cr | 9.07 | |
| Mar2022 | ₹18 Cr | 112.79 | |
| Mar2021 | ₹8.67 Cr | - | |
Compare Sundry Debtors of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹335.8 Cr | -0.8% | -1.8% | -33.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -0.8% |
-1.8% |
-33.9% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses